Grajales-González HM, Munive-Báez L, de la Teja-Ángeles E

Language: Spanish
References: 16
Page: 253-257
PDF size: 152.87 Kb.

ABSTRACT

Multiple sclerosis is a chronic autoimmune inflammatory disease of the central nervous system, characterized by the presence of acute focal inflammatory demyelination, axonal loss and gliosis. It affects predominantly in young adults between 20 and 40 years of age; it is infrequent in the pediatric age. A observational, retrospective and descriptive cohort research was conducted between May 1999 and January 2012 to assess demographic characteristics, and pathological manifestations in the oral cavity of children with this condition. Records of 17 patients, under 18 years of age, of either sex were included, who had been evaluated in the Department of Stomatology. Data recorded were age, sex, State of origin, oral and facial pathological features, focal cavity infections and ceod index. There were no patients with trigeminal neuralgia or facial paralysis; a 5.7% ceod index was identified. Most of the patients were under immunopressive treatment. A protocol for stomatological follow-up in patients with multiple sclerosis does not exist. The medical profession must be sensibilized to establish strategies for an integral follow-up in patients with this condition.

REFERENCES

1. Scardina GA, Carini F, Fuca G, Valenza V, Messina P. Multiple Sclerosis: Oral Manifestations and Dental Implications. J Biol Sci. 2007;2(4):444-8.

2. Gallud L, Bagan JV, Cervelló A, Jiménez Y, Poveda R, Gavalda C. Sclerosis Multiple as first manifestation in oral and facial area: Presentation of four cases. Med Oral Patol Oral Cir Bucal. 2006;11(2):141-5.

3. Sacramento T, Correia RP, Barral D, Souza E, Arriaga M. Orofacial changes in patients with multiple sclerosis treated in Brasil. Int J Med Sci. 2011;3(1):139-43.

4. Deryck O, Ketelaer P, Dubois B. Clinical characteristics and long term prognosis in early onset multiple sclerosis. J Neurol. 2006;253(6):720-3.

5. Craelius W. Comparative epidemiology of multiple sclerosis and dental caries. J Epidemiol Commun Health. 1978;32(1):155-65.

6. Danesh SA, Rahimdoost A, Mahmood S, Ghiyasi M, Haghdoost N, Sabzali S. Clinical assessment of orofacial manifestations in 500 patients with multiple sclerosis. J Oral Maxillofac Surg. 2012;1(1): 1-5.

7. Fischer DJ, Epstein JB, Klasser G. Multiple sclerosis: an update for oral health care providers. OOOOE. 2009;108(3):318-28.

8. Chemaly D, Lefrancois A, Perusse R. Oral and maxillofacial manifestations of multiple sclerosis. J Can Dent Assoc. 2000;66(11):600-5.

9. Badel T, Carek A, Podoreski D, Savic I, Kocijan S. Temporomandibular joint disorder in a patient with multiple sclerosis- Review of literature with a clinical report. Coll Antropol. 2010;34(3):1155-9.

10. Boppana S, Huang H, Ito K, Dhib S. Immunologic aspects of multiple sclerosis. Mt Sinai J Med. 2011;78(2):207-20.

11. Kovac Z, Uhac I, Bukovic D, Cabov T, Kovacevic D, Grzic R. Oral health status and temporomandibular disorders in multiple sclerosis patients. Coll Antropol. 2005;29(2):441-4.

12. Nylander A, Hafler DA. Multiple sclerosis. J Clin Invest. 2012; 22(4):1180-8.

13. Griffiths JC, Trimlett J. Dental status and barriers to care for adults with multiple sclerosis. Int Dent J. 199; 2(1):114.

14. Cantorna MT. Vitamin D and multiple sclerosis: an update. Nutr Rev. 2008;66(10 Suppl 2)S:135-8.

15. Rajabally YA, Farrell D, Messios N. Oro-Mandibular Dystonia in a Case of Multiple Sclerosis with Capsular Plaque. Eur Neurol. 2003;49(3):190-1.

16. Santa Eulalia E, Martínez EM, Miegimolle M, Planellsdel P. Oral health status of a population with multiple sclerosis. Med Oral Patol Oral Cir Bucal. 2012;17(2):223-7.